Mesoblast Debt Ratio from 2010 to 2025

MESO Stock

USD 18.69 0.13 0.69%

Mesoblast Debt Ratio yearly trend continues to be very stable with very little volatility. Debt Ratio is likely to drop to 0.11. During the period from 2010 to 2025, Mesoblast Debt Ratio quarterly data regression pattern had sample variance of 0 and median of 0.11. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.16

Current Value

0.11

Quarterly Volatility

0.03616203

Credit Downgrade

Yuan Drop

Covid

Check Mesoblast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesoblast's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 24.9 M or Selling General Administrative of 20.5 M, as well as many indicators such as Price To Sales Ratio of 122, Dividend Yield of 0.0 or PTB Ratio of 1.5. Mesoblast financial statements analysis is a perfect complement when working with Mesoblast Valuation or Volatility modules.

Check out the analysis of Mesoblast Correlation against competitors.

To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.

Latest Mesoblast's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Mesoblast over the last few years. It is Mesoblast's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesoblast's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Mesoblast Debt Ratio Regression Statistics

	Arithmetic Mean	0.12
	Geometric Mean	0.11
	Coefficient Of Variation	30.92
	Mean Deviation	0.03
	Median	0.11
	Standard Deviation	0.04
	Sample Variance	0
	Range	0.0919
	R-Value	0.80
	Mean Square Error	0.0005
	R-Squared	0.64
	Significance	0.0002
	Slope	0.01
	Total Sum of Squares	0.02

Mesoblast Debt Ratio History

	2025	0.11
	2023	0.18
	2022	0.17
	2021	0.16
	2019	0.14
	2018	0.12

Other Fundumenentals of Mesoblast

Cash Flow To Debt Ratio

Mesoblast Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Debt	Common Stock	Net Tangible Assets	Property Plant Equipment	Deferred Long Term Liab	Long Term Investments	Net Invested Capital	Net Working Capital	Long Term Debt	Long Term Debt Total	Short Long Term Debt	Capital Stock
Total Assets		0.95	-0.07	-0.11	0.68	0.1	0.88	0.63	0.94	-0.15	0.64	0.26	0.05	-0.15	0.07	0.04	0.01	0.02	0.06	-0.03	0.01	0.06	0.01
Total Stockholder Equity	0.95		-0.01	-0.22	0.67	0.16	0.7	0.55	0.91	-0.24	0.54	0.35	0.17	0.12	0.11	-0.2	-0.06	0.15	0.18	-0.02	0.09	0.0	0.07
Net Debt	-0.07	-0.01		-0.67	-0.1	0.28	-0.16	-0.39	0.07	-0.15	0.37	-0.06	0.6	0.1	0.12	-0.5	-0.54	0.49	-0.18	0.6	0.57	-0.64	0.56
Retained Earnings	-0.11	-0.22	-0.67		0.06	-0.21	0.09	0.38	-0.27	0.44	-0.37	-0.03	-0.94	-0.37	-0.52	0.77	0.8	-0.81	0.15	-0.71	-0.84	0.84	-0.87
Accounts Payable	0.68	0.67	-0.1	0.06		-0.2	0.58	0.29	0.71	0.0	0.56	0.57	-0.21	-0.09	0.05	0.01	0.31	-0.17	0.26	-0.33	-0.3	0.24	-0.31
Net Receivables	0.1	0.16	0.28	-0.21	-0.2		-0.02	0.04	0.1	0.03	0.15	0.18	0.22	0.17	-0.25	-0.22	-0.24	0.36	0.31	0.22	0.13	-0.02	0.23
Total Liab	0.88	0.7	-0.16	0.09	0.58	-0.02		0.64	0.81	0.01	0.67	0.06	-0.15	-0.53	-0.01	0.41	0.1	-0.2	-0.13	-0.04	-0.12	0.15	-0.09
Total Current Assets	0.63	0.55	-0.39	0.38	0.29	0.04	0.64		0.33	-0.08	0.05	-0.17	-0.37	-0.21	0.06	0.56	0.3	-0.21	0.06	-0.32	-0.28	0.4	-0.24
Intangible Assets	0.94	0.91	0.07	-0.27	0.71	0.1	0.81	0.33		-0.13	0.76	0.39	0.19	-0.12	0.03	-0.16	-0.1	0.08	0.04	0.09	0.11	-0.07	0.09
Current Deferred Revenue	-0.15	-0.24	-0.15	0.44	0.0	0.03	0.01	-0.08	-0.13		-0.13	-0.21	-0.47	-0.5	-0.63	0.29	0.21	-0.59	-0.21	0.06	-0.39	0.1	-0.45
Good Will	0.64	0.54	0.37	-0.37	0.56	0.15	0.67	0.05	0.76	-0.13		0.42	0.29	-0.34	0.07	-0.11	-0.27	0.25	-0.16	0.24	0.3	-0.17	0.29
Short Term Debt	0.26	0.35	-0.06	-0.03	0.57	0.18	0.06	-0.17	0.39	-0.21	0.42		-0.03	0.33	-0.1	-0.35	0.11	0.09	0.48	-0.41	-0.19	0.39	-0.19
Common Stock	0.05	0.17	0.6	-0.94	-0.21	0.22	-0.15	-0.37	0.19	-0.47	0.29	-0.03		0.42	0.57	-0.75	-0.85	0.84	-0.12	0.75	0.9	-0.8	0.93
Net Tangible Assets	-0.15	0.12	0.1	-0.37	-0.09	0.17	-0.53	-0.21	-0.12	-0.5	-0.34	0.33	0.42		0.41	-0.7	-0.2	0.57	0.55	-0.11	0.27	-0.1	0.25
Property Plant Equipment	0.07	0.11	0.12	-0.52	0.05	-0.25	-0.01	0.06	0.03	-0.63	0.07	-0.1	0.57	0.41		-0.24	-0.41	0.64	0.02	0.18	0.55	-0.37	0.59
Deferred Long Term Liab	0.04	-0.2	-0.5	0.77	0.01	-0.22	0.41	0.56	-0.16	0.29	-0.11	-0.35	-0.75	-0.7	-0.24		0.55	-0.67	-0.15	-0.39	-0.61	0.6	-0.53
Long Term Investments	0.01	-0.06	-0.54	0.8	0.31	-0.24	0.1	0.3	-0.1	0.21	-0.27	0.11	-0.85	-0.2	-0.41	0.55		-0.62	0.44	-0.82	-0.79	0.69	-0.91
Net Invested Capital	0.02	0.15	0.49	-0.81	-0.17	0.36	-0.2	-0.21	0.08	-0.59	0.25	0.09	0.84	0.57	0.64	-0.67	-0.62		0.16	0.42	0.85	-0.59	0.8
Net Working Capital	0.06	0.18	-0.18	0.15	0.26	0.31	-0.13	0.06	0.04	-0.21	-0.16	0.48	-0.12	0.55	0.02	-0.15	0.44	0.16		-0.49	-0.31	0.39	-0.3
Long Term Debt	-0.03	-0.02	0.6	-0.71	-0.33	0.22	-0.04	-0.32	0.09	0.06	0.24	-0.41	0.75	-0.11	0.18	-0.39	-0.82	0.42	-0.49		0.7	-0.82	0.81
Long Term Debt Total	0.01	0.09	0.57	-0.84	-0.3	0.13	-0.12	-0.28	0.11	-0.39	0.3	-0.19	0.9	0.27	0.55	-0.61	-0.79	0.85	-0.31	0.7		-0.83	0.9
Short Long Term Debt	0.06	0.0	-0.64	0.84	0.24	-0.02	0.15	0.4	-0.07	0.1	-0.17	0.39	-0.8	-0.1	-0.37	0.6	0.69	-0.59	0.39	-0.82	-0.83		-0.75
Capital Stock	0.01	0.07	0.56	-0.87	-0.31	0.23	-0.09	-0.24	0.09	-0.45	0.29	-0.19	0.93	0.25	0.59	-0.53	-0.91	0.8	-0.3	0.81	0.9	-0.75

Click cells to compare fundamentals

About Mesoblast Financial Statements

Mesoblast investors utilize fundamental indicators, such as Debt Ratio, to predict how Mesoblast Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Debt Ratio	0.16	0.11
Cash Flow To Debt Ratio	(0.37)	(0.39)

When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:

How To Invest In Mesoblast

Details

Is Mesoblast Stock a good investment?

Details

What is Mesoblast's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Mesoblast Correlation against competitors.

To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.05)

Revenue Per Share

0.06

Quarterly Revenue Growth

(0.41)

Return On Assets

(0.05)

Return On Equity

(0.18)

The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mesoblast Debt Ratio from 2010 to 2025

Latest Mesoblast's Debt Ratio Growth Pattern

Mesoblast Debt Ratio Regression Statistics

Mesoblast Debt Ratio History

Other Fundumenentals of Mesoblast

Mesoblast Debt Ratio component correlations

About Mesoblast Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY